Aug 2 |
Vertex Stock: Came For CF Drugs, Staying For Gene Therapy
|
Aug 2 |
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
|
Aug 2 |
Vertex Pharmaceuticals Incorporated 2024 Q2 - Results - Earnings Call Presentation
|
Aug 2 |
Vertex Pharmaceuticals, Inc. (VRTX) Q2 2024 Earnings Call Transcript
|
Aug 1 |
Vertex Pharmaceuticals (VRTX) Reports Q2 Loss, Misses Revenue Estimates
|
Aug 1 |
Vertex Slumps As Guidance Hike — Featuring The Gene-Editing Launch — Fails To Erase Losses
|
Aug 1 |
Vertex: Q2 Earnings Snapshot
|
Aug 1 |
Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments
|
Aug 1 |
Vertex Pharmaceuticals Non-GAAP EPS of -$12.83 misses by $1.08, revenue of $2.65B misses by $10M
|
Aug 1 |
Vertex Reports Second Quarter 2024 Financial Results
|